Marksans Pharma

{
  "main_header": {
    "sid": 604869,
    "name": "Marksans Pharma",
    "stock_name": "Marksans Pharma",
    "full_name": "Marksans Pharma Ltd",
    "name_url": "stocks-analysis/marksans-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "181.25",
    "chg": 16.9,
    "chgp": "10.28%",
    "dir": 1,
    "prev_price": "164.35",
    "mcapval": "8,388.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 524404,
    "symbol": "MARKSANS",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE750C01026",
    "curr_date": "Feb 03",
    "curr_time": "",
    "bse_nse_vol": "34.74 lacs",
    "exc_status": "Active",
    "traded_date": "Feb 03, 2026",
    "traded_date_str": "2026 02 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/marksans-pharma-604869-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Marksans Pharma Ltd Opens with Strong Gap Up Reflecting Positive Market Sentiment",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/marksans-pharma-ltd-opens-with-strong-gap-up-reflecting-positive-market-sentiment-3817924",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/MarksansPharmaL_gapup_3817924.png",
        "date": "2026-02-03 09:56:09",
        "description": "Marksans Pharma Ltd witnessed a significant gap up at the opening bell on 3 February 2026, surging 9.46% higher than its previous close. This robust start underscores a positive market sentiment towards the pharmaceutical company amid a broader sectoral uptick."
      },
      {
        "title": "Marksans Pharma Ltd Hits Intraday High with 13.14% Surge on 3 Feb 2026",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/marksans-pharma-ltd-hits-intraday-high-with-1314-surge-on-3-feb-2026-3817665",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/MarksansPharmaL_priceRelatedfactors_3817665.png",
        "date": "2026-02-03 09:41:30",
        "description": "Marksans Pharma Ltd recorded a robust intraday performance on 3 Feb 2026, surging to a day’s high of Rs 186.6, marking a 13.54% increase from the previous close. This strong upward momentum outpaced both its sector and the broader market, reflecting notable trading activity and positive price action throughout the session."
      },
      {
        "title": "Marksans Pharma Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/marksans-pharma-ltd-is-rated-sell-3814204",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/MarksansPharmaL_mojoScore_3814204.png",
        "date": "2026-02-01 10:10:04",
        "description": "Marksans Pharma Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 07 July 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 February 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Marksans Pharma Ltd Stock Falls to 52-Week Low of Rs.157.25",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/marksans-pharma-ltd-stock-falls-to-52-week-low-of-rs15725-3811338",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/MarksansPharmaL_priceRelatedfactors_3811338.png",
        "date": "2026-01-30 11:01:01",
        "description": "Marksans Pharma Ltd has touched a new 52-week low of Rs.157.25 today, marking a significant decline in its stock price amid broader market fluctuations and sectoral pressures. This fresh low reflects ongoing challenges faced by the company in maintaining growth momentum and investor confidence over the past year."
      },
      {
        "title": "Marksans Pharma Ltd Falls to 52-Week Low Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/marksans-pharma-ltd-falls-to-52-week-low-amidst-continued-downtrend-3805658",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/MarksansPharmaL_priceRelatedfactors_3805658.png",
        "date": "2026-01-27 10:14:39",
        "description": "Marksans Pharma Ltd’s shares declined to a fresh 52-week low of Rs.159.15 on 27 Jan 2026, marking a significant downturn amid broader market resilience. The stock has underperformed its sector and major indices, reflecting ongoing concerns about its recent financial performance and investor participation."
      },
      {
        "title": "Marksans Pharma Ltd Faces Bearish Technical Shift Amid Mixed Momentum Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/marksans-pharma-ltd-faces-bearish-technical-shift-amid-mixed-momentum-signals-3799487",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/MarksansPharmaL_technicaldot_3799487.png",
        "date": "2026-01-22 08:00:55",
        "description": "Marksans Pharma Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a transition from mildly bearish to a more pronounced bearish trend. Despite a modest day gain of 0.62%, the stock’s broader technical landscape suggests caution for investors amid mixed signals from MACD, RSI, and moving averages."
      },
      {
        "title": "Marksans Pharma Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/marksans-pharma-ltd-is-rated-sell-3798183",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/MarksansPharmaL_mojoScore_3798183.png",
        "date": "2026-01-21 10:10:37",
        "description": "Marksans Pharma Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 07 Jul 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 January 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Marksans Pharma Ltd Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/marksans-pharma-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-3795248",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/MarksansPharmaL_technicaldot_3795248.png",
        "date": "2026-01-20 08:03:08",
        "description": "Marksans Pharma Ltd has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across key indicators. Despite a recent upgrade from a Hold to a Sell rating by MarketsMOJO on 7 July 2025, the stock’s price action and technical parameters suggest a cautiously evolving outlook for investors in the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Marksans Pharma Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/marksans-pharma-ltd-is-rated-sell-3788113",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/MarksansPharmaL_mojoScore_3788113.png",
        "date": "2026-01-10 10:10:05",
        "description": "Marksans Pharma Ltd is rated 'Sell' by MarketsMOJO. This rating was last updated on 07 Jul 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 10 January 2026, providing investors with the latest insights into the company’s performance and outlook."
      }
    ],
    "total": 316,
    "sid": "604869",
    "stock_news_url": "https://www.marketsmojo.com/news/marksans-pharma-604869"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Acquisition",
      "datetime": "27-Jan-2026",
      "details": "Incorporation of two new wholly owned subsidiary Companies",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "22-Jan-2026",
      "details": "The Company has scheduled a conference call for analysts and investors on Friday February 06 2026 at 04:00 PM (IST) to discuss the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended December 31 2025.",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "13-Jan-2026",
      "details": "Certificate received from RTA under regulation 74(5) of SEBI (DP) regulations 2018 for the quarter ended December 31 2025",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "05 Feb 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Marksans Pharma Ltd has declared <strong>80%</strong> dividend, ex-date: 01 Aug 25",
          "dt": "2025-08-01",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Marksans Pharma Ltd has announced <strong>1:10</strong> stock split, ex-date: 11 Mar 08",
          "dt": "2008-03-11",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Marksans Pharma Ltd Opens with Strong Gap Up Reflecting Positive Market Sentiment

2026-02-03 09:56:09

Marksans Pharma Ltd witnessed a significant gap up at the opening bell on 3 February 2026, surging 9.46% higher than its previous close. This robust start underscores a positive market sentiment towards the pharmaceutical company amid a broader sectoral uptick.

Read full news article

Marksans Pharma Ltd Hits Intraday High with 13.14% Surge on 3 Feb 2026

2026-02-03 09:41:30

Marksans Pharma Ltd recorded a robust intraday performance on 3 Feb 2026, surging to a day’s high of Rs 186.6, marking a 13.54% increase from the previous close. This strong upward momentum outpaced both its sector and the broader market, reflecting notable trading activity and positive price action throughout the session.

Read full news article

Marksans Pharma Ltd is Rated Sell

2026-02-01 10:10:04

Marksans Pharma Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 07 July 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 February 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Marksans Pharma Ltd Stock Falls to 52-Week Low of Rs.157.25

2026-01-30 11:01:01

Marksans Pharma Ltd has touched a new 52-week low of Rs.157.25 today, marking a significant decline in its stock price amid broader market fluctuations and sectoral pressures. This fresh low reflects ongoing challenges faced by the company in maintaining growth momentum and investor confidence over the past year.

Read full news article

Marksans Pharma Ltd Falls to 52-Week Low Amidst Continued Downtrend

2026-01-27 10:14:39

Marksans Pharma Ltd’s shares declined to a fresh 52-week low of Rs.159.15 on 27 Jan 2026, marking a significant downturn amid broader market resilience. The stock has underperformed its sector and major indices, reflecting ongoing concerns about its recent financial performance and investor participation.

Read full news article

Marksans Pharma Ltd Faces Bearish Technical Shift Amid Mixed Momentum Signals

2026-01-22 08:00:55

Marksans Pharma Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a transition from mildly bearish to a more pronounced bearish trend. Despite a modest day gain of 0.62%, the stock’s broader technical landscape suggests caution for investors amid mixed signals from MACD, RSI, and moving averages.

Read full news article

Marksans Pharma Ltd is Rated Sell

2026-01-21 10:10:37

Marksans Pharma Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 07 Jul 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 January 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Marksans Pharma Ltd Technical Momentum Shifts Amid Mixed Indicator Signals

2026-01-20 08:03:08

Marksans Pharma Ltd has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across key indicators. Despite a recent upgrade from a Hold to a Sell rating by MarketsMOJO on 7 July 2025, the stock’s price action and technical parameters suggest a cautiously evolving outlook for investors in the Pharmaceuticals & Biotechnology sector.

Read full news article

Marksans Pharma Ltd is Rated Sell

2026-01-10 10:10:05

Marksans Pharma Ltd is rated 'Sell' by MarketsMOJO. This rating was last updated on 07 Jul 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 10 January 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

View All News